Prince Constantijn of the Netherlands chairman of the Hartwig Medical Foundation Supervisory Board
On July 14, Prince Constantijn of the Netherlands succeeded Robbert Dijkgraaf as chairman of the Supervisory Board of Hartwig Medical Foundation.
Prince Constantijn works with a variety of organizations that aim to support and stimulate technology and innovation.
With Prince Constantijn as chairman, we expect to continue to make progress progress in the field of technology and innovation. We look forward to working together.
All news
Also read
Clinical Cancer Genomics conference, March 20-21 2025, Amsterdam
We are pleased to announce that registration for this novel exciting meeting focused on cancer whole genome and transcriptome sequencing …
Warnyta Minnaard represents patient interests and possibilities
Frank van Wijck, science journalist Warnyta Minnaard has been a member of Hartwig Medical Foundation’s Data Access Board (DAB) since February …
Join us for an evening of Healthcare Tech innovation with Hartwig Medical Foundation and GCUG
Calling all software developers and tech enthusiasts 🚀 Hartwig Medical Foundation partners with Google Cloud User Group (GCUG) to bring …
Cancer is caused by DNA mutations. There are an increasing number of drugs available that act on specific errors in the DNA of an individual patient’s tumor. A drug that doesn’t fit, like a key in a lock, will not work, while the risk of side effects remains.